tirzepatide and nicotine Does (a dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist) aid in smoking cessation? tirzepatide and nicotine glp1 #semaglutide
Description
It is a tolerability phase, allowing your body to adjust to the medication and minimize gastrointestinal side effects
Cardiovasc Diabetol 23 , 242 (2024)
The 2.5 mg starting dose is explicitly a tolerability dose in trials it was not intended to drive weight loss on its own, but to let the gut acclimate before therapeutic doses begin
Clinical trials of brand-name tirzepatide showed up to 22% body weight loss in the general population
Combining it with tirzepatide adds a receptor target (amylin) without the glucagon component that retatrutide provides
They may suggest treatment to manage the symptoms and advise whether it's safe to continue the medication .
